Prognosis, clinical outcomes and quality of life issues in cutaneous T-cell lymphoma

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 • 14,121 citations

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

1993 • 5,539 citations

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

2002 • 5,269 citations

Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use

1994 • 4,920 citations

World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues

2002 • 4,781 citations

Measuring Health-Related Quality of Life

1993 • 3,948 citations

Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

1999 • 3,484 citations

Assessment of Quality-of-Life Outcomes

1996 • 2,499 citations

A Critical Appraisal of the Quality of Quality-of-Life Measurements

1994 • 2,068 citations

World Health Organization classification of tumors

2000 • 1,998 citations

Basic and Clinical Biostatistics,

2002 • 1,862 citations

Measuring the quality of life of cancer patients

1981 • 1,562 citations

EORTC Classification for Primary Cutaneous Lymphomas: A Proposal From the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer

1997 • 1,298 citations

Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy

1987 • 1,177 citations

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

2002 • 1,076 citations

Analysis of survival by tumor response.

1983 • 1,021 citations

Analysis of survival by tumor response.

1986 • 1,018 citations

The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.

2001 • 979 citations

Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment

2000 • 738 citations

Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results

2001 • 685 citations

Skindex, a Quality-of-Life Measure for Patients with Skin Disease: Reliability, Validity, and Responsiveness

1996 • 678 citations

Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma

2001 • 612 citations

Sample size slippages in randomised trials: exclusions and the lost and wayward

2002 • 567 citations

Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas.

1979 • 548 citations

Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases

1997 • 444 citations

Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.

1996 • 426 citations

Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.

2001 • 418 citations

Lessons learned from measuring health-related quality of life in oncology.

1994 • 383 citations

Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system

1996 • 360 citations

Mycosis Fungoides

2000 • 354 citations

Subcutaneous Panniculitis-like T-Cell Lymphoma

1998 • 351 citations

Follicular Mycosis Fungoides, a Distinct Disease Entity With or Without Associated Follicular Mucinosis

2002 • 324 citations

Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patients

1999 • 293 citations

Quality of life measurement in dermatology: a practical guide

1997 • 289 citations

Clinical Stage IA (Limited Patch and Plaque) Mycosis Fungoides

1996 • 278 citations

Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis

1998 • 277 citations

Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis

1998 • 274 citations

Histopathologic Staging at Initial Diagnosis of Mycosis Fungoides and the Sézary Syndrome

1988 • 270 citations

Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients

2002 • 265 citations

Quantifying the harmful effect of psoriasis on health-related quality of life

2002 • 264 citations

Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases

2000 • 259 citations

Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes

1998 • 249 citations

Topical Corticosteroids for Mycosis Fungoides

1998 • 234 citations

Gemcitabine Treatment in Pretreated Cutaneous T-Cell Lymphoma: Experience in 44 Patients

2000 • 225 citations

Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: A 10-year experience at a single institution

1996 • 208 citations

Phase 1 and 2 Trial of Bexarotene Gel for Skin-Directed Treatment of Patients With Cutaneous T-Cell Lymphoma

2002 • 203 citations

CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides

1995 • 181 citations

Mycosis Fungoides and Sézary Syndrome

2023 • 177 citations

Clinical Characteristics and Long-term Outcome of Patients With Generalized Patch and/or Plaque (T2) Mycosis Fungoides

1999 • 174 citations

Prognostic factor analysis in mycosis fungoides/Sézary syndrome

1999 • 173 citations

Quality of life measurement in dermatology: a practical guide

1997 • 166 citations

Prognostic Factors in Erythrodermic Mycosis Fungoides and the Sézary Syndrome

1995 • 163 citations

Detection of a Peripheral Blood T Cell Clone is an Independent Prognostic Marker in Mycosis Fungoides

2000 • 159 citations

Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma

2001 • 157 citations

The Suitability of Quality-of-Life Questionnaires for Psoriasis Research

2002 • 152 citations

Natural Killer/Natural Killer-Like T-Cell Lymphoma, CD56+, Presenting in the Skin: An Increasingly Recognized Entity With an Aggressive Course

2001 • 152 citations

Antitumor activity of DAB389 IL-2 fusion toxin in mycosis fungoides

1998 • 139 citations

Isotretinoin and Cutaneous Helper T-Cell Lymphoma (Mycosis Fungoides)

1987 • 132 citations

Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy

1996 • 132 citations

Photopheresis therapy for cutaneous T-cell lymphoma

1996 • 130 citations

Convergent and Discriminant Validity of a Generic and a Disease-Specific Instrument to Measure Quality of Life in Patients with Skin Disease

1997 • 129 citations

Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides

2000 • 125 citations

Clinical Staging for Cutaneous T-Cell Lymphoma

1984 • 124 citations

Treatment of Cutaneous T-Cell Lymphoma With Combined Immunomodulatory Therapy

2002 • 123 citations

Prognostic factors in Sézary syndrome: A multivariate analysis of clinical, haematological and immunological features

1998 • 117 citations

Prognostic Factors in Primary Cutaneous Lymphomas Other Than Mycosis Fungoides and the Sézary Syndrome

1999 • 114 citations

Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective.

1996 • 113 citations

Clinical Characteristics and Outcome of Patients With Extracutaneous Mycosis Fungoides

2001 • 112 citations

Local Superficial Radiotherapy in the Management of Minimal Stage IA Cutaneous T-Cell Lymphoma (Mycosis Fungoides)

1998 • 112 citations

Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group.

1989 • 110 citations

Quality of life and the patient with cancer. Individual and policy implications

1994 • 106 citations

Mycosis fungoides: Clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factor

1980 • 106 citations

Spirituality and the Dying Patient

2003 • 101 citations

EORTC QLQ‐C30 and FACT‐BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison

2000 • 100 citations

Prognostic Clinicopathologic Factors in Cutaneous T-cell Lymphoma

1991 • 100 citations

Combined modality therapy for cutaneous T-cell lymphoma

1996 • 99 citations

The changing survival of patients with mycosis fungoides

1999 • 97 citations

Scalpdex

2002 • 95 citations

Quantifying Skin Disease Burden in Mycosis Fungoides–Type Cutaneous T-Cell Lymphomas

2002 • 94 citations

“High-dose” UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides

2001 • 91 citations

Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma [see comments]

1996 • 87 citations

Increased Serum Concentration of the Soluble Interleukin-2 Receptor in Cutaneous T-Cell Lymphoma

1996 • 85 citations

Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the S�zary syndrome)

1999 • 84 citations

Treatment of mycosis fungoides with recombinant interferon-αza2 alone and in combination with etretinate

1988 • 83 citations

Prognostic variables in mycosis fungoides

1981 • 82 citations

Spirituality and the Dying Patient

2000 • 80 citations

Quality of life and the patient with cancer. Individual and policy implications

1994 • 78 citations

Complete Remissions in Psoralen and UV-A (PUVA)-Refractory Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma With Combined Interferon Alfa and PUVA

1993 • 75 citations

Interstitial mycosis fungoides, a variant of mycosis fungoides resembling granuloma annulare and inflammatory morphea*

2002 • 73 citations

Advances in quality of life measurements in oncology patients

2002 • 70 citations

Pentostatin (2′-deoxycoformycin) in the treatment of cutaneous T-cell lymphoma

1997 • 67 citations

Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: A 9-year retrospective study at a single institution

2000 • 66 citations

Advances in quality of life measurements in oncology patients

2002 • 66 citations

Treatment of relapsing or recalcitrant cutaneous T-cell lymphoma with pegylated liposomal doxorubicin

2000 • 60 citations

A spiritual inventory of the medically ill patient.

1988 • 59 citations

Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma ? the D�sseldorf and Munich experience

1995 • 51 citations

Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis

1996 • 50 citations

Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the working formulation of non-Hodgkin's lymphomas for clinical usage

1994 • 50 citations

Extracorporeal photochemotherapy for cutaneous T‐cell lymphoma: a 9.7‐year experience

1999 • 48 citations

Tumor Burden Index as a Prognostic Tool for Cutaneous T-Cell Lymphoma

1999 • 42 citations

Combination of Etoposide, Idarubicin, Cyclophosphamide, Vincristine, Prednisone and Bleomycin (VICOP-B) in the Treatment of Advanced Cutaneous T-Cell Lymphoma

1997 • 38 citations

Role of histology in providing prognostic information in mycosis fungoides

1998 • 33 citations

Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma(mycosis fungoides and the Sézary syndrome)

1999 • 30 citations

Understanding Research about Quality of Life and other Health Outcomes

1999 • 27 citations

Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA

1993 • 26 citations

Molecular Genetics of Cutaneous Lymphomas

2001 • 26 citations

Prognostic factors in erythrodermic mycosis fungoides and the Sezary syndrome

1995 • 26 citations

Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides)

1987 • 24 citations

Assessing Clinical Outcomes in Cutaneous T-cell Lymphoma

1995 • 22 citations

Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications

1996 • 19 citations

Mycosis Fungoides and Sézary Syndrome

2011 • 17 citations

Prognostic clinicopathologic factors in cutaneous T-cell lymphoma

1991 • 16 citations

Why Event-Free Survival is Better than Tumor Response or other Measures of Survival as an Endpoint in Cancer Trials

1996 • 14 citations

Clinical Trials and Efficacy Assessment in the Therapy of Cutaneous T Cell Lymphoma

2001 • 12 citations

Consensus Development Conference: Assessment of the Quality of Life in Cancer Clinical Trials

1992 • 11 citations

Rationale of a new classification for the group of primary cutaneous lymphomas

2000 • 10 citations

Quality of care in dermatology. The state of (measuring) the art

1997 • 5 citations

Corrections

1996 • 1 citations

Cited By (0)

Loading...